SJS Investment Consulting’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7K Buy
480
+473
+6,757% +$4.56K ﹤0.01% 1238
2026
Q1
$52 Buy
+7
New +$74 ﹤0.01% 2247
2025
Q1
Sell
-11
Closed -$182 1650
2024
Q4
$182 Sell
11
-11
-50% -$171 ﹤0.01% 1470
2024
Q3
$325 Buy
22
+8
+57% +$125 ﹤0.01% 1431
2024
Q2
$195 Hold
14
﹤0.01% 1520
2024
Q1
$221 Sell
14
-2
-13% -$31 ﹤0.01% 1466
2023
Q4
$259 Buy
16
+7
+78% +$115 ﹤0.01% 1415
2023
Q3
$111 Hold
9
﹤0.01% 1535
2023
Q2
$145 Buy
+9
New +$148 ﹤0.01% 1466

Other funds holding NEO

SJS Investment Consulting's NEO Position: Q2 2026 in Review

SJS Investment Consulting increased its NeoGenomics (NEO) stake by 6,757% in Q2 2026, buying an estimated $4.56K and bringing the position to 480 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1238.

SJS Investment Consulting first reported a position in NEO in Q2 2023 and has held it in 9 quarters since. 57 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • SJS Investment Consulting held 480 shares of NeoGenomics worth $7K as of Q2 2026.
  • SJS Investment Consulting bought 473 NeoGenomics shares in Q2 2026, an estimated $4.56K.
  • NeoGenomics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1238 holding.
  • SJS Investment Consulting first reported a position in NeoGenomics in Q2 2023 and has held it in 9 quarters since.
  • 57 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.